Biomarkers Market Size, Share & Trends Analysis Report By Type (Safety, Efficacy), By Application (Diagnostics, Personalized Medicine), By Disease (Neurological Diseases, Cancer), By Region, And Segment Forecasts, 2023 - 2030
- Report ID: 978-1-68038-979-1
- Number of Pages: 150
- Format: Electronic (PDF)
- Historical Range: 2018 - 2021
- Industry:Healthcare
Market Segmentation
- Biomarkers Type Outlook (Revenue, USD Billion, 2018 - 2030)
- Safety
- Efficacy
- Validation
- Biomarkers Application Outlook (Revenue, USD Billion, 2018 - 2030)
- Diagnostics
- 药物发现& Development
- Personalized Medicine
- Others
- Biomarkers Disease Outlook (Revenue, USD Billion, 2018 - 2030)
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Biomarkers Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
- North America Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- North America Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- North America Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- U.S.
- U.S. Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- U.S. Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- U.S. Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- U.S. Biomarkers Market, By Type
- Canada
- Canada Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Canada Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Canada Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Canada Biomarkers Market, By Type
- North America Biomarkers Market, By Type
- Europe
- Europe Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Europe Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Europe Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- U.K.
- U.K. Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- U.K. Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- U.K. Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- U.K. Biomarkers Market, By Type
- Germany
- Germany Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Germany Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Germany Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Germany Biomarkers Market, By Type
- France
- France Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- France Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- France Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- France Biomarkers Market, By Type
- Italy
- Italy Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Italy Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Italy Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Italy Biomarkers Market, By Type
- Spain
- Spain Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Spain Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Spain Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Spain Biomarkers Market, By Type
- Denmark
- Denmark Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Denmark Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Denmark Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Denmark Biomarkers Market, By Type
- Sweden
- Sweden Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Sweden Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Sweden Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Sweden Biomarkers Market, By Type
- Norway
- Norway Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Norway Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Norway Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Norway Biomarkers Market, By Type
- Asia Pacific
- Asia Pacific Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Asia Pacific Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Asia Pacific Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Japan
- Japan Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Japan Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Japan Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Japan Biomarkers Market, By Type
- China
- China Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- China Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- 中国生物标志物的市场,通过疾病
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- China Biomarkers Market, By Type
- India
- India Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- India Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- India Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- India Biomarkers Market, By Type
- South Korea
- South Korea Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- South Korea Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- South Korea Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- South Korea Biomarkers Market, By Type
- Australia
- Australia Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Australia Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Australia Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Australia Biomarkers Market, By Type
- Thailand
- Thailand Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Thailand Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Thailand Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Thailand Biomarkers Market, By Type
- Asia Pacific Biomarkers Market, By Type
- Latin America
- Latin America Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Latin America Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Latin America Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Brazil
- Brazil Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Brazil Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Brazil Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Brazil Biomarkers Market, By Type
- Mexico
- Mexico Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Mexico Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Mexico Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Mexico Biomarkers Market, By Type
- Argentina
- Argentina Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Argentina Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Argentina Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Argentina Biomarkers Market, By Type
- Middle East & Africa
- Middle East & Africa Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Middle East & Africa Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Middle East & Africa Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- South Africa
- South Africa Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- South Africa Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- South Africa Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- South Africa Biomarkers Market, By Type
- Saudi Arabia
- Saudi Arabia Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Saudi Arabia Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Saudi Arabia Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Saudi Arabia Biomarkers Market, By Type
- UAE
- UAE Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- UAE Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- UAE Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- UAE Biomarkers Market, By Type
- Kuwait
- Kuwait Biomarkers Market, By Type
- Safety
- Efficacy
- Validation
- Kuwait Biomarkers Market, By Application
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
- Kuwait Biomarkers Market, By Disease
- Cancer
- Safety
- Efficacy
- Validation
- Cardiovascular Diseases
- Safety
- Efficacy
- Validation
- Neurological Diseases
- Safety
- Efficacy
- Validation
- Immunological Diseases
- Safety
- Efficacy
- Validation
- Others
- Safety
- Efficacy
- Validation
- Cancer
- Kuwait Biomarkers Market, By Type
- Middle East & Africa Biomarkers Market, By Type
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- 乐鱼体育手机网站入口
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us nowto get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.
